Gabelli & CO Investment Advisers, Inc. Vor Biopharma Inc. Transaction History
Gabelli & CO Investment Advisers, Inc.
- $518 Million
- Q4 2024
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 30,000 shares of VOR stock, worth $37,800. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$37,800% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VOR
# of Institutions
54Shares Held
54.9MCall Options Held
20.9KPut Options Held
2.1K-
Ra Capital Management, L.P. Boston, MA39.6MShares$50 Million0.71% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$8.02 Million3.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.45 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$1.35 Million0.41% of portfolio
-
Lynx1 Capital Management LP San Juan, PR637KShares$802,8940.27% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $48M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...